HALEY TIMOTHY M
Known title: DirectorCIK: 0001201583
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Netflix shares drop 25% following chief content officer departure. Netflix stock fell sharply as the company announced the departure of its chief content officer. Analysts note the firm is taking steps to address engagement issues, but the leadership change has created significant market pressure. The stock is now trading near its 52-week low, reflecting investor uncertainty about future content strategy.
Transaction History
| TDUP | ▲ Buy | Grant | 2,491 | $0 | 7/20/2026 | View on chart |
| TDUP | ▲ Buy | Grant | 37,265 | $0 | 5/20/2026 | View on chart |
| TDUP | ▲ Buy | Grant | 3,836 | $0 | 4/22/2026 | View on chart |
| TDUP | ▲ Buy | Grant | 2,432 | $0 | 2/25/2026 | View on chart |
| TDUP | ▲ Buy | Grant | 43,814 | $0 | 5/21/2025 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 647 | $63K | 11/11/2024 | View on chart |
| NFLX | ▼ Sell | Open Market | 647 | $518K | 11/11/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 1,001 | $50K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 465 | $50K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 398 | $50K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 672 | $63K | 11/5/2024 | View on chart |
| NFLX | ▼ Sell | Open Market | 536 | $406K | 11/5/2024 | View on chart |
| NFLX | ▼ Sell | Open Market | 7,920 | $6.0M | 11/5/2024 | View on chart |
| NFLX | ▼ Sell | Open Market | 1,066 | $809K | 11/5/2024 | View on chart |
| NFLX | ▼ Sell | Open Market | 970 | $737K | 11/5/2024 | View on chart |
| NFLX | ▼ Sell | Open Market | 498 | $379K | 11/5/2024 | View on chart |
| NFLX | ▼ Sell | Open Market | 100 | $76K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 791 | $50K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 615 | $62K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 847 | $50K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 728 | $50K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 630 | $50K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 532 | $50K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 447 | $50K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 472 | $50K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 472 | $50K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 560 | $50K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 569 | $63K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 664 | $62K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 636 | $63K | 11/5/2024 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 591 | $62K | 11/5/2024 | View on chart |
| TDUP | ▲ Buy | Grant | 7,713 | $0 | 7/24/2024 | View on chart |
| TDUP | ▲ Buy | Grant | 77,363 | $0 | 4/22/2024 | View on chart |
| TDUP | ▲ Buy | Grant | 7,092 | $0 | 4/22/2024 | View on chart |
| TDUP | ▲ Buy | Grant | 6,357 | $0 | 2/26/2024 | View on chart |
| TDUP | ▲ Buy | Grant | 3,910 | $0 | 10/17/2023 | View on chart |
| TDUP | ▲ Buy | Grant | 4,843 | $0 | 8/2/2023 | View on chart |
| NFLX | ▼ Sell | Open Market | 1,022 | $460K | 7/5/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 1,022 | $50K | 7/5/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 903 | $50K | 6/9/2023 | View on chart |
| NFLX | ▼ Sell | Open Market | 903 | $384K | 6/9/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 735 | $50K | 5/30/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 798 | $50K | 5/30/2023 | View on chart |
| NFLX | ▼ Sell | Open Market | 2,359 | $945K | 5/30/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 826 | $50K | 5/30/2023 | View on chart |
| TDUP | ▲ Buy | Grant | 55,872 | $0 | 5/24/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 742 | $50K | 5/10/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 1,043 | $50K | 5/10/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 959 | $50K | 5/10/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 784 | $50K | 5/10/2023 | View on chart |
| NFLX | ▼ Sell | Open Market | 4,137 | $1.4M | 5/10/2023 | View on chart |
| NFLX | ▼ Sell | Open Market | 3,010 | $1.0M | 5/10/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 868 | $50K | 5/10/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 826 | $50K | 5/10/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 966 | $50K | 5/10/2023 | View on chart |
| NFLX | ▲ Buy | Option Exercise | 959 | $50K | 5/10/2023 | View on chart |
| TDUP | ▲ Buy | Grant | 5,122 | $0 | 5/3/2023 | View on chart |
| TDUP | ▲ Buy | Grant | 8,234 | $0 | 2/15/2023 | View on chart |
| TDUP | ▲ Buy | Grant | 8,987 | $0 | 11/1/2022 | View on chart |
| TDUP | ▲ Buy | Grant | 6,144 | $0 | 8/2/2022 | View on chart |
| TDUP | ▲ Buy | Grant | 19,613 | $0 | 5/26/2022 | View on chart |
| TDUP | ▲ Buy | Grant | 1,798 | $0 | 5/25/2022 | View on chart |
| TDUP | ▲ Buy | Grant | 1,324 | $0 | 2/14/2022 | View on chart |
| TDUP | ▼ Sell | Other | 483 | $0 | 11/9/2021 | View on chart |
| TDUP | ▼ Sell | Other | 6,063 | $0 | 11/9/2021 | View on chart |
| TDUP | ▼ Sell | Other | 2,348,745 | $0 | 11/9/2021 | View on chart |
| TDUP | ▼ Sell | Other | 2,348,745 | $0 | 11/9/2021 | View on chart |
| TDUP | ▼ Sell | Other | 60,224 | $0 | 11/9/2021 | View on chart |
| TDUP | ▼ Sell | Other | 60,224 | $0 | 11/9/2021 | View on chart |
| TDUP | ▲ Buy | Grant | 654 | $0 | 11/3/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
ThredUp Featured in Resale and GLP-1 Market Analysis
ThredUp was highlighted in recent articles discussing how resale and rental marketplaces are adapting to the GLP-1 weight-loss drug trend. One piece also listed the stock among growth opportunities to watch. These mentions focus on the company's position in the circular fashion economy rather than specific financial results.
ThredUp Featured in Resale and GLP-1 Market Analysis. ThredUp was highlighted in recent articles discussing how resale and rental marketplaces are adapting to the GLP-1 weight-loss drug trend. One piece also listed the stock among growth opportunities to watch. These mentions focus on the company's position in the circular fashion economy rather than specific financial results.